Deep Learning-Assisted Computer-Aided Diagnosis System for Early Detection of Lung Cancer.

J Clin Ultrasound

Department of Electronics and Communication Engineering, PSN College of Engineering and Technology, Tirunelveli, India.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: The largest cause of cancer-related fatalities worldwide is lung cancer. The dimensions and positioning of the primary tumor, the presence of lesions, the type of lung cancer like malignant or benign, and the good mental health diagnosis all play a part in the diagnosis of the disease.

Methods: Three processes should be used by standard computer-assisted diagnosis (CAD) systems to detect lung cancer: preprocessing, feature extraction, and classification. Fast nonlocal means filter is first used for preprocessing (FNLM). The lung pictures are processed using the Binary Grasshopper Optimization Algorithm (BGOA) to extract the features.

Results: The 10 levels of the neural network architecture which automatically gathers data and categorizes them are added to the current study's suggested model, which subtracts the five levels of Imagenet. Using the same Modèle dataset, the proposed model was compared to deep learning techniques.

Conclusion: In terms of accuracy and sensitivity, the suggested model performed better than the existing techniques (99.53% accuracy and 98.95% sensitivity). The effectiveness of the suggested strategy is superior to that of alternative methods when it is near the true positive values at the ROC curve.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.23929DOI Listing

Publication Analysis

Top Keywords

lung cancer
16
suggested model
8
lung
5
deep learning-assisted
4
learning-assisted computer-aided
4
diagnosis
4
computer-aided diagnosis
4
diagnosis system
4
system early
4
early detection
4

Similar Publications

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.

JAMA Netw Open

September 2025

Oncostat U1018, Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France.

Importance: Antibiotics, steroids, and proton pump inhibitors (PPIs) are suspected to decrease the efficacy of immunotherapy.

Objective: To explore the association of comedications with overall survival (OS) in patients with advanced non-small-cell lung cancer (NSCLC).

Design, Setting, And Participants: This nationwide retrospective cohort study used target trial emulations of patients newly diagnosed with NSCLC from January 2015 to December 2022, identified from the French national health care database.

View Article and Find Full Text PDF

Objective: This study aims to systematically evaluate the inter- and intra-observer agreement regarding lesions with uncertain malignancy potential in Ga-68 PSMA PET/CT imaging of prostate cancer patients, utilizing the PSMA-RADS 2.0 classification system, and to emphasize the malignancy evidence associated with these lesions.

Methods: We retrospectively reviewed Ga-68 PSMA PET/CT images of patients diagnosed with prostate cancer via histopathology between December 2016 and November 2023.

View Article and Find Full Text PDF

Background: Lung cancer (LC) is the leading cause of cancer-related deaths globally. Genetic variants in mismatch repair (MMR) genes, such as MutS homolog 2 (MSH2), MutS homolog 6 (MSH6) and MutL homolog 1 (MLH1), may influence individual susceptibility and clinical outcomes in LC.

Objective: This study investigated the associations of genetic polymorphisms in MSH2, MSH6, and MLH1 with susceptibility and survival outcomes in lung cancer patients in the Guangxi Zhuang population.

View Article and Find Full Text PDF

Introduction: Pancreatic adenocarcinomas (PDAC) have a poor prognosis, with a 5-year relative Survival rate of 11.5%. Only 20% of patients are initially eligible for resection, and 50% of patients presented with metastatic disease, currently only candidates' palliative treatment.

View Article and Find Full Text PDF

IL12-based phototherapeutic nanoparticles through remodeling tumor-associated macrophages combined with immunogenic tumor cell death for synergistic cancer immunotherapy.

Biomater Sci

September 2025

Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, The Tianjin Key Laboratory of Biomaterials, Institute of Biomedical Engineering, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin, 300192, China.

Various cancer therapeutic strategies have been designed for targeting tumor-associated macrophages (TAMs), but TAM reprogramming-based monotherapy is often clinically hindered, likely due to the lack of a coordinated platform to initiate T cell-mediated immunity. Herein, we fabricated reactive oxygen species (ROS)-responsive human serum albumin (HSA)-based nanoparticles (PEG/IL12-IA NPs) consisting of indocyanine green (ICG), arginine (Arg), and interleukin 12 (IL12). Upon laser irradiation, the nanoparticles were found to be able to dissociate, thus facilitating the release of IL12.

View Article and Find Full Text PDF